Ascorbate attenuates the systemic kainate-induced neurotoxicity in the rat hippocampus

Brain Research

Volumn 727, Issue 1-2, 1996, Pages 133-144

  MacGregor, D G ^a   Higgins, M J ^a   Jones, P A ^a   Maxwell, W L ^a   Watson, M W ^a   Graham, D I ^a   Stone, T W ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Allopurinol; Ascorbic acid; Free radical; Kainic acid; Neurodegeneration; Neuroprotection; Vitamin C

Indexed keywords

ALLOPURINOL; ASCORBIC ACID; KAINIC ACID; NEUROPROTECTIVE AGENT; OXIPURINOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HIPPOCAMPUS; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030586340     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00362-9     Document Type: Article

References (70)

1. [1] Aizenman, E., Hartnett, K.A. and Reynolds, I.J., Oxygen free radicals regulate NMDA receptor function via a redox modulatory site, Neuron, 5 (1990) 841-846.
2. [2] Altar, C.A. and Baudry, M., Systemic injection of kainic acid: gliosis in olfactory and limbic brain regions quantified with [3H]PK11195 binding autoradiography, Exp. Neurol., 109 (1990) 333-341.
3. [3] Armstead, W.M., Mirro, R., Leffler, C.W. and Busija, D.W., Cerebral superoxide anion generation during seizures in newborn pigs, J. Cereb. Blood Flow Metab., 9 (1989) 175-179.
4. [4] Balchen, T., Berg, M. and Diemer, N.H., A paradox after systemic kainate injection in rats - lesser damage of hippocampal CA1 neurons after higher doses, Neurosci. Lett., 163 (1993) 151-154.
5. [5] Beal, M.F., Kowall, N.W., Swartz, K.J., Ferrante, R.J. and Martin, J.B., Systemic approaches to modifying quinolinic acid striatal lesions in rats, J. Neurosci., 8 (1988) 3901-3908.
6. [6] Ben-Ari, Y., Tremblay, E., Riche, D., Ghilini, G. and Naquet, R., Electrographic clinical and pathological alterations following systemic administration of kainic acid, bicuculine or pentetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy, Neuroscience, 6 (1981) 1361-1391.
7. [7] Bose, R., Schnell, C.L., Pinsky, C. and Zitko, V., Effects of excitotoxins on free radical indices in mouse brain, Toxicol. Lett., 60 (1992) 211-219.
8. [8] Brown, A.W. and Brierley, J.B., Anoxic-ischaemic cell change in rat brain. Light microscopic and fine structural observations, J. Neurol. Sci., 16 (1972) 59-84.
9. [9] Cammack, J., Ghasemzadeh, B. and Adams, R.N., The pharmacological profile of glutamate-evoked ascorbic acid efflux measured by in vivo electrochemistry. Brain Res., 565 (1991) 17-22.
10. [10] Choi, D.W. and Rothman, S.M., The role of glutamate neurotoxicity in hypoxic ischaemic neuronal death, Annu. Rev. Neurosci., 13 (1990) 171-182.
11. [11] Connick, J.H. and Stone, T.W., The effects of quinolinic, kainic and beta-kainic acids on the release of endogenous glutamate from rat brain slices, Biochem. Pharmacol., 35 (1986) 3631-3635.
12. [12] Coyle, J.T., Kainic acid: insights into excitatory mechanism causing selective neuronal degredation. In Selective Neuronal Death (Ciba Foundation Symposium 126). Wiley, Chichester, 1987, pp. 186-203.
13. [13] Coyle, J.T. and Puttfarcken, P., Oxidative stress, glutamate and neurodegenerative disorders, Science, 262 (1993) 689-695.
14. [14] Diemer, N.H., Johansen, F.F. and Jorgensen, M.B., NMDA and non-NMDA antagonists in global cerebral ischaemia, Stroke, 21 (Suppl. 3) (1990) 39-42.
15. [15] Dykens, J.A., Stern, A. and Trenkner, E., Mechanisms of kainate toxicity to cellular neurones in vitro as analogous to reperfusion tissue injury, J. Neurochem., 49 (1987) 1222-1228.
16. 3H]-Ro 05-4864 in trout and mouse brain membranes, J. Neurosci., 53 (1989) 494-502.
17. [17] Facchinetti, F., Virgili, M., Contestabile, A. and Barnabei, O., Antagonists of the NMDA receptor and allopurinol protect the olfactory cortex but not the striatum after intracerebral injection of kainic acid, Brain Res., 585 (1992) 330-334.
18. [18] Ferkany, J.W., Zaczek, R. and Coyle, J.T., Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors, Nature, 298 (1982) 757-759.
19. [19] Franck, J.E. and Roberts, D.L., Combined kainate and ischaemia produce 'mesial temporal sclerosis', Neurosci. Lett., 118 (1990) 159-163.
20. [20] Franck, J.E. and Schwartzkroin, P.A., Immature rabbit hippocampus is damaged by systemic but not intraventricular kainic acid injection, Dev. Brain Res., 13 (1984) 219-227.
21. [21] Fuller, T.A. and Olney, J.W., Only certain anticonvulsants protect against kainate neurotoxicity, Neurobehav. Toxicol. Teratol. 3 (1981) 355-361.
22. 3H]-aspartate from cerebral cortical synaptosomes, J. Neurochem., 62 (1994) 1757-1763.
23. [23] Hall, E.D., Andrus, P.K., Althaus, J.S. and von Voigtlander, P.F., Hydroxyl radical production and lipid peroxidation parallels selective post-ischaemic vulnerability in gerbil brain, J. Neurosci. Res., 34 (1993) 107-112.
24. [24] Hara, H. and Kogure, K., Prevention of hippocampus neuronal damage in ischaemic gerbils by a novel lipid peroxidation inhibitor (quinazoline derivative), J. Pharrnacol. Exp. Ther., 255 (1990) 906-910.
25. [25] Harman, D., Free radical theory of aging: a hypothesis on pathogenesis of senile dementia of the Alzheimer type, Age, 16 (1993) 23-30.
26. [26] Heggli, D.A. and Malthe-Sorensen, D., Systemic injection of kainic acid: effect on neurotransmitter markers in pyriform cortex, amygdaloid complex and hippocampus and protection by cortical lesioning and anticonvulsants, Neuroscience, 7 (1982) 1257-1264.
27. [27] Heggli, D.A., Aamodt, A. and Malthe-Sorensen, D., Kainic acid neurotoxicity: effect of systemic injection on neurotransmitter markers in different brain regions, Brain Res., 230 (1981) 253-262.
28. [28] Kirino, T., Tamura, A. and Sano, K., Selective vulnerability of the hippocampus to ischemia - reversible and irreversible types of ischemic cell damage, Prog. Brain Res., 63 (1985) 39-58.
29. [29] Kitagawa, K., Matsumoto, M., Oda, T., Ninobe, M., Hata, R., Handa, N., Fukunaga, R., Isaka,Y., Kimura, K., Maeda, H., Mikoshiba, K. and Kamada, T., Free radical generation during brief period of cerebral ischaemia may trigger delayed neuronal death, Neuroscience, 35 (1990) 551-558.
30. [30] Kohler, C., Schwarcz, R. and Fuxe, K., Hippocampal lesions indicate differences between the excitotoxic properties of acidic amino acids, Brain Res., 175 (1979) 366-371.
31. [31] Kuzmin, A.I., Tskitishvili, O.V., Serebryakova, V.I., Kapelko, V.I. and Majorova, I.V., Allopurinol: kinetics, inhibition of xanthine oxidase activity and protective effect in ischaemic-reperfused canine heart as studied by cardiac microdialysis, J. Cardiovasc. Pharmacol., 25 (1995) 564-571.
32. [32] Lafon-Cazal, M., Pietri, S., Culcasi, M. and Bockaert, J., NMDA-dependent superoxide production and neurotoxicity, Nature, 364 (1993) 535-537.
33. [33] Lagerwall, K., Daneryd, P., Schersten, T. and Soussi, B., In vivo P31 NMR evidence of the salvage effect of ascorbate on the postischaemic reperfused rat skeletal muscle, Life Sci., 56 (1994) 389-397.
34. [34] Lin, Y. and Phillis, J.W., Deoxycoformycin and oxypurinol: protection against focal ischemic brain injury in the rat. Brain Res., 571 (1991) 272-280.
35. [35] Lothman, E.W. and Collins, R.C., Kainic acid induced limbic seizures: metabolic, behavioural, electroencephalographic and neuropathological correlates, Brain Res., 218 (1981) 299-318.
36. [36] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.A., Protein measurements with the folin phenol reagent, J. Biol. Chem., 193 (1951) 265-275.
37. [37] Lysko, P.G., Lysko, K.A., Yue, T.L., Webb, C.L., Gu, J.L. and Feuerstein, G., Neuroprotective effects of Carvedilol, new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischaemia, Stroke, 23 (1992) 1630-1636.
38. 6-phenylisopropyladenosine, of kainic acid neurotoxicity in rat hippocampus after systemic administration, Br. J. Pharmacol., 109 (1993) 316-321.
39. [39] MacGregor, D.G., Miller, W.J. and Stone, T.W., Mediation of the neuroprotective action of R-phenylisopropyladenosine through a centrally located adenosine A1 receptor, Br. J. Pharmacol., 110 (1993) 470-476.
40. [40] MacDermott, A.B., Mayer, M.L., Westbrook, G.L., Smith, S.J. and Barker, J.L., NMDA receptor activation increases cytoplasmic calcium concentrations in cultured spinal cord neurones, Nature, 321 (1986) 519-522.
41. [41] Magloczky, Z and Freund, T.F., Selective neuronal death in the contralateral hippocampus following unilateral kainate injections into the CA3 subfield, Neuroscience, 56 (1993) 317-336.
42. [42] Majewska, M.D. and Bell, J.A., Ascorbic acid protects neurons from injury induced by glutamate and NMDA, NeuroReport, 1 (1990) 194-196.
43. [43] Majewska, M.D., Bell, J.A. and London, E.D., Regulation of the NMDA receptor by redox phenomena: inhibitory role of ascorbate, Brain Res., 537 (1990) 328-332.
44. [44] Mena, M.A., Pardo, B., Paino, C.L. and Yebenes, J.G.D., Levodopa toxicity in foetal rat midbrain neurones in culture: modulation by ascorbic acid, NeuroReport, 4 (1993) 438-440.
45. [45] Miyamoto, M. and Coyle, J.T., Idebenone attenuates neuronal degeneration induced by intrastriatal injections of excitotoxins, Exp. Neurol., 108 (1990) 38-45.
46. [46] Munns, P.L. and Leach, K.L., Two novel antioxidants, U74006F and U78517F, inhibit oxidant-stimulated calcium influx, Free Radical Biol. Med., 18 (1995) 467-478.
47. [47] Nadler, J.V., Perry, B.W., Gentry, C. and Cotman, C.W., Degeneration of hippocampal CA3 pyramidal cells induced by intraventricular kainic acid, J. Comp. Neurol., 192 (1980) 333-359.
48. [48] Oury, T.D., Pinatodosi, C.A. and Crapo, J.D., Cold-induced brain edema in mice, J. Biol. Chem., 268 (1993) 15394-15398.
49. [49] Palmer, A.M., Reiter, C.T. and Botscheller, M., Comparison of the release of exogenous anhd endogenous excitatory amino acids from rat cerebral cortex, Ann. NY Acad Sci. (1992) 648, 361-364.
50. [50] Pazdernik, T.L., Layton, M., Nelson, S.R. and Samson, F.E., The osmotic/calcium stress theory of brain damage: are free radicals involved?, Neurochem. Res., 17 (1992) 11-21.
51. [51] Peruche, B. and Krieglstein, J., Mechanisms of drug actions against neuronal damage caused by ischaemia - an overview. Progr. Neuropsychopharm, Biol. Psychiat., 17 (1993) 21-70.
52. [52] Phillis, J.W. and Sen, S., Oxypurinol attenuates hydroxyl radical production during ischemia/reperfusion injury of the rat cerebral cortex: an ESR study, Brain Res., 628 (1993) 309-312.
53. [53] Pulsinelli, W.A., Brierley, J.B. and Plum, F. (1982) Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol., 11, 491-498.
54. [54] Puttfarcken, P.S., Getz, R.L. and Coyle, J.T., Kainic acid induced lipid peroxidation - protection with butylated hydroxytoluene and U78517F in primary cultures of cerebellar granule cells, Brain Res., 624 (1993) 223-232.
55. [55] Saija, A., Princi, P., Pisani, A., Lanza, M., Scalese, M., Aramnejad, E., Ceserani, R. and Costa, G., Protective effect of glutathione on kainic acid induced neuropathological changes in rat brain, Gen. Pharmacol., 25 (1994) 97-102.
56. [56] Schwarcz, R., Foster, A.C., French, E.D., Whetsell, W.O. and Kohler, C., II. Excitotoxic models for neurodegenerative disorders, Life Sci., 35 (1984) 19-32.
57. [57] Schwob, J.E., Fuller, T., Price, J.L. and Olney, J.W., Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study, Neuroscience, 5 (1980) 991-1014.
58. [58] Sciamanna, M.A. and Lee, C.P., Ischaemia-reperfusion-induced injury of forebrain mitochondria and protection by ascorbate, Arch. Biochem. Biophys., 305 (1993) 215-224.
59. [59] Sharma, S.K., Johnstone, R.M. and Quastel, J.H., Active transport of ascorbic acid in adrenal cortex and brain cortex in vitro and the effects of ACTH and steroids, Can. J. Biochem. Physiol., 41 (1963) 597-604.
60. [60] Siesjo, B.K., Agardh, C.-D. and Bengtsson, F., Free radicals and brain damage, Cerebrovasc. Brain Metab. Rev., 1 (1989) 165-211.
61. [61] Spector, R., Penetration of ascorbic acid from cerebrospinal fluid into brain, Exp. Neurol., 72 (1981). 643-653.
62. [62] Spector, T., Oxypurinol as an inhibitor of xanthine oxidase-catalyzed production of superoxide radical, Biochem. Pharmacol., 37 (1987) 349-352.
63. [63] Sperk, G., Lassmann, H., Baran, H., Kish, S.J., Seitelberger, F. and Hornykiewicz, O., Kainic acid induced seizures: neurochemical and histopathological changes, Neuroscience, 10 (1983) 1301-1315.
64. [64] Stone, T.W., The neuropharmacology of quinolinic and kynurenic acids, Pharmacol. Rev., 45 (1993) 309-379.
65. [65] Sun, A.Y., Cheng, Y., Bu, Q. and Oldfield, F. the biochemical mechanisms of the excitotoxicity of kainic acid - free radical formation, Mol. Chem. Neuropathol., 17 (1992) 51-63.
66. [66] Tauck, D.L., Redox modulation of NMDA receptor mediated synaptic activity in the hippocampus, NeuroReport, 3 (1992) 781-784.
67. [67] Taylor, M.D., Palmer, G.C. and Callahan, A.S., Protective action of methylprednisolone, allopurinol and indomethacin against stroke induced damage to adenylate cyclase in gerbil hippocampus, Stroke, 15 (1984) 329-335.
68. [68] Volterra, A., Trotti, D. and Racagni, G., Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms, Mol. Pharmacol., 446 (1994) 986-992.
69. [69] Wilson, J., Ascorbic acid uptake by a high-affinity sodium-dependent mechanism in cultures rat astrocytes, J. Neurochem., 53 (1989) 1064-1071.
70. [70] Yue, T.L., McKenna, P.J., Gu, J.L., Cheng, H.Y., Ruffolo, R.R. and Feuerstein, G.Z., Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells, Hypertension, 22 (1993) 922-928.